Omega Healthcare Expands AI Collaboration with Microsoft to Transform Revenue Cycle Management

15 July 2025 | Tuesday | News

Leveraging Azure AI Foundry and the Omega Digital Platform, over 20 generative AI solutions deployed to automate complex workflows, reduce costs, and boost financial performance in healthcare

Omega Healthcare, a leading provider of technology-enabled RCM services, announced  an expanded collaboration with Microsoft to further enhance its advanced AI capabilities across the revenue cycle. Through the integration of Microsoft Azure cutting-edge AI models through Azure AI Foundry, and the company's proprietary Omega Digital Platform (ODP), Omega Healthcare launched more than 20 generative and agentic AI solutions to help healthcare organizations enhance revenue cycle operations and improve financial performance.

Since establishing the relationship with Microsoft in 2023, Omega Healthcare has rapidly deployed these solutions leveraging intelligent automation within its ODP framework helping healthcare organizations automate complex workflows, such as correspondence processing, appeal filing, denial management, and call center support—while increasing accuracy, compliance, and profitability for its customers.

"By combining the strength of our RCM and healthcare expertise with Microsoft's advanced large language models, we are unlocking new efficiencies, previously considered by the market as too complex to automate," said Anurag Mehta, CEO and Co-Founder, Omega Healthcare. "We are bringing scalable, tech-enabled services without requiring healthcare leaders to take on large, risky technology investments, freeing them up to focus on what matters most – delivering exceptional patient care."

"Omega Healthcare is one of the most innovative partners we've worked with in applying Microsoft Azure AI Foundry capabilities – including Azure OpenAI in Foundry Models – to revenue cycle management and other real-world healthcare challenges," said Elena Bonfiglioli, General Manager, Worldwide Healthcare at Microsoft. "Their ability to translate AI innovation into practical, high-impact solutions across the entire revenue cycle and beyond, has positioned them as a clear leader in tech-enabled RCM transformation."

The AI solutions incorporate Microsoft Azure's intelligent automation engines that are seamlessly integrated across the ODP, supporting the full revenue cycle: patient access, mid-cycle operations, and back-end processes. These modules combine advanced AI models in Azure AI Foundry with Omega Healthcare's deep domain expertise to automate routine processes, such as medical coding and integrate with ODP's AI/ML models to support key services for customers, such as clinical documentation improvement (CDI), denials management and prevention. For example, ODP can automate routine tasks across the revenue cycle, including standard denial processes, evidence retrieval, and appeal submission. Key outcomes include up to 75% reductions in AR follow-up days, faster resolution times, and improved compliance.

Omega Healthcare has also launched additional solutions for payers unleashing new potential for retrospective HCC coding automation and has deployed solutions for areas like data curation for life sciences.

"The possibilities are endless as we continue building new AI-powered capabilities across the healthcare ecosystem in collaboration with Microsoft and our customers," added Mehta.

Highlighting the additional promise for the future of AI innovation in healthcare, a recent Everest Group survey, concluded an overwhelming majority (85%) of senior healthcare executives surveyed believe AI will improve efficiencies in RCM operations over the next five years. 

"We are thrilled to be a pioneer in driving RCM transformation," emphasized Mehta. "Our customers are already experiencing the benefits of generative and agentic AI and are excited about future developments as we work together and continue to innovate."

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close